NVCR
NovoCure Ltd
+0.56 (+3.45%)16.78USD325K成交股數2.0B市值–本益比(近四季)2.8股價營收比+15.6%營收年增(近四季)2026-10-29下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 940K |
| 近 180 天 淨額 | −940K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 07-01 | Ben Arye Barak | General Counsel | A 獲配股票 | 1.3K | 11.15 | 14K | 244K | SEC |
| 2026-06-30 | 07-01 | Leonard Frank X | Chief Executive Officer | A 獲配股票 | 1.9K | 11.15 | 21K | 461K | SEC |
| 2026-06-30 | 07-01 | Danziger Asaf | Director | A 獲配股票 | 268 | 11.15 | 3K | 417K | SEC |
| 2026-06-30 | 07-01 | Puri Michal Nath | Chief Human Resources Officer | A 獲配股票 | 1.9K | 11.15 | 21K | 203K | SEC |
| 2026-06-04 | 06-05 | Leonard Frank X | Chief Executive Officer | S 公開市場賣出 | 34.3K | 17.93 | 615K | 460K | SEC |
| 2026-06-03 | 06-05 | Madden Martin J. | Director | A 獲配股票 | 11.6K | – | – | 30.3K | SEC |
| 2026-06-03 | 06-05 | Hung David | Director | A 獲配股票 | 11.6K | – | – | 32.1K | SEC |
| 2026-06-03 | 06-05 | LEUNG GABRIEL | Director | A 獲配股票 | 11.6K | – | – | 101K | SEC |
| 2026-06-03 | 06-05 | VERNON W ANTHONY | Director | A 獲配股票 | 11.6K | – | – | 209K | SEC |
| 2026-06-03 | 06-05 | HILLEMAN JERYL L | Director | A 獲配股票 | 11.6K | – | – | 25.5K | SEC |
| 2026-06-03 | 06-05 | Scannell Timothy J | Director | A 獲配股票 | 11.6K | – | – | 25.9K | SEC |
| 2026-06-03 | 06-05 | Ocean Allyson J | Director | A 獲配股票 | 11.6K | – | – | 22.9K | SEC |
| 2026-06-03 | 06-05 | Stafford Kristin | Director | A 獲配股票 | 11.6K | – | – | 22.9K | SEC |
| 2026-06-02 | 06-03 | Stafford Kristin | Director | S 公開市場賣出 | 2.9K | 15.77 | 46K | 11.3K | SEC |
| 2026-06-02 | 06-03 | Scannell Timothy J | Director | S 公開市場賣出 | 2.9K | 15.77 | 46K | 14.3K | SEC |
| 2026-06-02 | 06-03 | LEUNG GABRIEL | Director | S 公開市場賣出 | 2.9K | 15.77 | 46K | 89.5K | SEC |
| 2026-06-02 | 06-03 | Hung David | Director | S 公開市場賣出 | 2.9K | 15.77 | 46K | 20.5K | SEC |
| 2026-06-02 | 06-03 | VERNON W ANTHONY | Director | S 公開市場賣出 | 2.9K | 15.77 | 46K | 198K | SEC |
| 2026-06-02 | 06-03 | Ocean Allyson J | Director | S 公開市場賣出 | 2.9K | 15.77 | 46K | 11.3K | SEC |
| 2026-06-02 | 06-03 | HILLEMAN JERYL L | Director | S 公開市場賣出 | 2.9K | 15.77 | 46K | 13.9K | SEC |
| 2026-04-28 | 04-28 | VERNON W ANTHONY | Director | M 選擇權執行 | 21.5K | 11.39 | 245K | 201K | SEC |
| 2026-03-05 | 03-05 | Paravasthu Mukund | Chief Operating Officer | S 公開市場賣出 | 43.2K | 13.77 | 595K | 72.8K | SEC |
| 2026-03-04 | 03-05 | Leonard Frank X | Chief Executive Officer | S 公開市場賣出 | 5.6K | 13.31 | 75K | 494K | SEC |
| 2026-03-04 | 03-05 | Cordova Ashley | Former Chief Executive Officer | F 繳稅扣股 | 17.6K | 13.30 | 235K | 423K | SEC |
| 2026-03-04 | 03-05 | Weinberg Uri | Chf Medical and Innovation Ofr | S 公開市場賣出 | 6.4K | 13.31 | 85K | 267K | SEC |
| 2026-03-04 | 03-05 | Brackmann Christoph | Chief Financial Officer | S 公開市場賣出 | 6.4K | 13.31 | 85K | 183K | SEC |
| 2026-03-04 | 03-05 | Paravasthu Mukund | Chief Operating Officer | S 公開市場賣出 | 5.4K | 13.31 | 72K | 116K | SEC |
| 2026-03-04 | 03-05 | Leupin Nicolas | Former Chief Medical Officer | S 公開市場賣出 | 1.1K | 13.31 | 15K | 103K | SEC |
| 2026-03-04 | 03-05 | Puri Michal Nath | Chief Human Resources Officer | S 公開市場賣出 | 1.1K | 13.31 | 15K | 201K | SEC |
| 2026-03-03 | 03-05 | Ben Arye Barak | General Counsel | A 獲配股票 | 50.1K | – | – | 242K | SEC |
| 2026-03-03 | 03-05 | Leonard Frank X | Chief Executive Officer | A 獲配股票 | 150K | – | – | 499K | SEC |
| 2026-03-03 | 03-05 | Weinberg Uri | Chf Medical and Innovation Ofr | A 獲配股票 | 50.1K | – | – | 274K | SEC |
| 2026-03-03 | 03-05 | DOYLE WILLIAM F | Executive Chairman | S 公開市場賣出 | 50.6K | 12.79 | 647K | 350K | SEC |
| 2026-03-03 | 03-05 | DOYLE WILLIAM F | Executive Chairman | S 公開市場賣出 | 21.3K | 13.43 | 286K | 328K | SEC |
| 2026-03-03 | 03-05 | DOYLE WILLIAM F | Executive Chairman | A 獲配股票 | 200K | – | – | 400K | SEC |
| 2026-03-03 | 03-05 | DOYLE WILLIAM F | Executive Chairman | A 獲配股票 | 200K | – | – | 200K | SEC |
| 2026-03-03 | 03-05 | Brackmann Christoph | Chief Financial Officer | A 獲配股票 | 55.1K | – | – | 189K | SEC |
| 2026-03-03 | 03-05 | Puri Michal Nath | Chief Human Resources Officer | A 獲配股票 | 40.1K | – | – | 202K | SEC |
| 2026-03-03 | 03-05 | Paravasthu Mukund | Chief Operating Officer | A 獲配股票 | 45.1K | – | – | 121K | SEC |
| 2026-03-02 | 03-03 | Paravasthu Mukund | Chief Operating Officer | S 公開市場賣出 | 408 | 13.49 | 6K | 76.3K | SEC |
| 2026-03-02 | 03-03 | Leonard Frank X | Chief Executive Officer | S 公開市場賣出 | 7.2K | 13.49 | 98K | 349K | SEC |
| 2026-03-02 | 03-03 | Cordova Ashley | Former Chief Executive Officer | F 繳稅扣股 | 7.2K | 13.67 | 99K | 440K | SEC |
| 2026-03-02 | 03-03 | Cordova Ashley | Former Chief Executive Officer | F 繳稅扣股 | 2.4K | 13.67 | 33K | 447K | SEC |
| 2026-03-02 | 03-03 | Weinberg Uri | Chf Medical and Innovation Ofr | S 公開市場賣出 | 3.3K | 13.33 | 44K | 223K | SEC |
| 2026-02-28 | 03-03 | Leonard Frank X | Chief Executive Officer | A 獲配股票 | 18.6K | – | – | 357K | SEC |
| 2026-02-28 | 03-03 | Ben Arye Barak | General Counsel | A 獲配股票 | 17.8K | – | – | 192K | SEC |
| 2026-02-28 | 03-03 | Cordova Ashley | Former Chief Executive Officer | A 獲配股票 | 23.8K | – | – | 450K | SEC |
| 2026-02-28 | 03-03 | Weinberg Uri | Chf Medical and Innovation Ofr | A 獲配股票 | 13.0K | – | – | 227K | SEC |
| 2026-02-27 | 03-03 | Weinberg Uri | Chf Medical and Innovation Ofr | S 公開市場賣出 | 7.5K | 13.84 | 103K | 214K | SEC |
| 2026-02-27 | 03-03 | Paravasthu Mukund | Chief Operating Officer | S 公開市場賣出 | 1.6K | 13.66 | 21K | 76.8K | SEC |
| 2026-02-27 | 03-03 | Leupin Nicolas | Former Chief Medical Officer | S 公開市場賣出 | 1.0K | 13.66 | 14K | 104K | SEC |
| 2026-02-27 | 03-03 | Puri Michal Nath | Chief Human Resources Officer | S 公開市場賣出 | 1.4K | 13.66 | 20K | 162K | SEC |
| 2026-02-27 | 03-03 | Leonard Frank X | Chief Executive Officer | S 公開市場賣出 | 9.7K | 13.66 | 133K | 338K | SEC |
| 2026-02-27 | 03-03 | Cordova Ashley | Former Chief Executive Officer | F 繳稅扣股 | 11.5K | 13.75 | 159K | 426K | SEC |
| 2026-01-11 | 01-12 | Paravasthu Mukund | Chief Operating Officer | F 繳稅扣股 | 2.1K | 14.35 | 31K | 78.3K | SEC |
| 2025-12-31 | 01-08 | Danziger Asaf | Director | A 獲配股票 | 1 | 10.99 | 10.99 | 416K | SEC |
| 2025-12-31 | 01-08 | Ben Arye Barak | General Counsel | A 獲配股票 | 108 | 10.99 | 1K | 175K | SEC |
| 2025-12-31 | 01-08 | Puri Michal Nath | Chief Human Resources Officer | A 獲配股票 | 1 | 10.99 | 10.99 | 164K | SEC |
| 2025-11-04 | 11-04 | Brackmann Christoph | Chief Financial Officer | F 繳稅扣股 | 7.0K | 12.23 | 86K | 134K | SEC |
| 2025-11-04 | 11-04 | Paravasthu Mukund | Chief Operating Officer | F 繳稅扣股 | 2.9K | 12.23 | 36K | 80.4K | SEC |
| 2025-11-01 | 11-04 | Paravasthu Mukund | Chief Operating Officer | F 繳稅扣股 | 168 | 12.81 | 2K | 83.4K | SEC |
| 2025-11-01 | 11-04 | Leonard Frank X | EVP, Pres., Novocure Oncology | F 繳稅扣股 | 966 | 12.81 | 12K | 348K | SEC |
| 2025-10-31 | 11-04 | Puri Michal Nath | Chief Human Resources Officer | F 繳稅扣股 | 752 | 12.82 | 10K | 164K | SEC |
| 2025-09-05 | 09-08 | Cordova Ashley | Chief Executive Officer | P 公開市場買進 | 81.5K | 12.22 | 997K | 438K | SEC |
| 2025-07-29 | 07-30 | Brackmann Christoph | Chief Financial Officer | P 公開市場買進 | 5.0K | 11.50 | 58K | 141K | SEC |
| 2025-07-29 | 07-30 | Brackmann Christoph | Chief Financial Officer | P 公開市場買進 | 5.0K | 11.60 | 58K | 136K | SEC |
| 2025-07-29 | 07-30 | Brackmann Christoph | Chief Financial Officer | P 公開市場買進 | 10.0K | 11.63 | 116K | 131K | SEC |
| 2025-06-30 | 07-01 | Ben Arye Barak | General Counsel | A 獲配股票 | 769 | 15.13 | 12K | 174K | SEC |
| 2025-06-30 | 07-01 | Puri Michal Nath | Chief Human Resources Officer | A 獲配股票 | 833 | 15.13 | 13K | 165K | SEC |
| 2025-06-30 | 07-01 | Danziger Asaf | Director | A 獲配股票 | 833 | 15.13 | 13K | 416K | SEC |
| 2025-06-30 | 07-01 | Cordova Ashley | Chief Executive Officer | A 獲配股票 | 833 | 15.13 | 13K | 356K | SEC |
| 2025-06-30 | 07-01 | Leonard Frank X | EVP, Pres., Novocure Oncology | A 獲配股票 | 833 | 15.13 | 13K | 349K | SEC |
| 2025-06-04 | 06-06 | LEUNG GABRIEL | Director | A 獲配股票 | 11.2K | – | – | 92.4K | SEC |
| 2025-06-04 | 06-06 | Stafford Kristin | Director | A 獲配股票 | 11.2K | – | – | 14.3K | SEC |
| 2025-06-04 | 06-06 | HILLEMAN JERYL L | Director | A 獲配股票 | 11.2K | – | – | 16.8K | SEC |
| 2025-06-04 | 06-06 | Ocean Allyson J | Director | A 獲配股票 | 11.2K | – | – | 14.3K | SEC |
| 2025-06-04 | 06-06 | Scannell Timothy J | Director | A 獲配股票 | 11.2K | – | – | 17.2K | SEC |
| 2025-06-04 | 06-06 | Hung David | Director | A 獲配股票 | 11.2K | – | – | 23.4K | SEC |
| 2025-06-04 | 06-06 | VERNON W ANTHONY | Director | A 獲配股票 | 11.2K | – | – | 179K | SEC |
| 2025-06-04 | 06-06 | Leonard Frank X | EVP, Pres., Novocure Oncology | A 獲配股票 | 179K | – | – | 348K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 17.4M | 263M | +304K (+2%) | 加碼 |
| BlackRock, Inc. | 13.4M | 203M | +220K (+2%) | 加碼 |
| Soleus Capital Management, L.P. | 9.9M | 150M | −579K (-6%) | 減碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.3M | 95.0M | +20.8K (+0%) | 加碼 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.9M | 74.3M | +222K (+5%) | 加碼 |
| MORGAN STANLEY | 4.5M | 68.5M | −19.1K (-0%) | 減碼 |
| STATE STREET CORP | 2.9M | 43.4M | +305K (+12%) | 加碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.8M | 42.4M | +287K (+11%) | 加碼 |
| WELLS FARGO & COMPANY/MN | 2.5M | 38.3M | −423K (-14%) | 減碼 |
| Quantinno Capital Management LP | 2.2M | 33.7M | −264K (-11%) | 減碼 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 2.0M | 29.6M | +400K (+26%) | 加碼 |
| JPMORGAN CHASE & CO | 1.7M | 25.9M | +741K (+80%) | 加碼 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.4M | 21.0M | +659K (+91%) | 加碼 |
| Palo Alto Investors LP | 1.3M | 19.4M | 不變 | 持平 |
| Nuveen, LLC | 1.2M | 18.7M | +250K (+25%) | 加碼 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.2M | 17.6M | −167K (-13%) | 減碼 |
| Empowered Funds, LLC | 1.2M | 17.5M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 1.1M | 16.7M | +827K (+301%) | 加碼 |
| DIMENSIONAL FUND ADVISORS LP | 1.1M | 16.5M | +132K (+14%) | 加碼 |
| 德劭 D. E. Shaw & Co., Inc. | 1.0M | 15.5M | +375K (+58%) | 加碼 |
| NORTHERN TRUST CORP | 973K | 14.7M | +89.6K (+10%) | 加碼 |
| GOLDMAN SACHS GROUP INC | 964K | 14.6M | +218K (+29%) | 加碼 |
| BAILLIE GIFFORD & CO | 952K | 14.4M | −120K (-11%) | 減碼 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 929K | 14.1M | +144K (+18%) | 加碼 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 924K | 14.0M | +86.2K (+10%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 216 -8 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 32 / 40 / 89 / 59 |
| 機構合計持股 · 佔流通股 | 103M · 88.9% |
| 合計季末市值 | 1.5B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 10.8M |
|---|---|
| 與上期比 | +17.6% |
| 佔流通股數 | 9.27% |
| 日均成交量 | 1.4M |
| 回補天數 | 7.6 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 10.8M | +17.6% | 9.27% | 1.4M | 7.6 |
| 2026-08-14 | 9.2M | -9.5% | 7.87% | 1.1M | 8.4 |
| 2026-07-31 | 10.1M | -11.5% | 8.71% | 2.1M | 4.9 |
| 2026-07-15 | 11.5M | -3.6% | 9.84% | 1.5M | 7.5 |
| 2026-06-30 | 11.9M | +23.1% | 10.21% | 1.9M | 6.2 |
| 2026-06-15 | 9.7M | +5.4% | 8.29% | 1.6M | 6.0 |
| 2026-05-29 | 9.2M | +7.2% | 7.86% | 1.3M | 6.9 |
| 2026-05-15 | 8.5M | +22.6% | 7.33% | 2.0M | 4.3 |
| 2026-04-30 | 7.0M | -20.0% | 5.98% | 1.7M | 4.1 |
| 2026-04-15 | 8.7M | -3.8% | 7.48% | 1.1M | 8.2 |
| 2026-03-31 | 9.1M | +6.3% | 7.78% | 1.3M | 7.1 |
| 2026-03-13 | 8.5M | -6.7% | 7.32% | 1.4M | 6.0 |
| 2026-02-27 | 9.1M | +2.6% | 7.84% | 2.6M | 3.6 |
| 2026-02-13 | 8.9M | +11.7% | 7.64% | 3.7M | 2.4 |
| 2026-01-30 | 8.0M | +7.2% | 6.84% | 1.0M | 7.7 |
| 2026-01-15 | 7.4M | -10.8% | 6.38% | 1.3M | 5.6 |
| 2025-12-31 | 8.3M | +20.0% | 7.16% | 1.1M | 7.8 |
| 2025-12-15 | 6.9M | +1.7% | 5.96% | 2.3M | 3.1 |
| 2025-11-28 | 6.8M | +14.3% | 5.86% | 1.5M | 4.7 |
| 2025-11-14 | 6.0M | +4.5% | 5.13% | 1.9M | 3.2 |
| 2025-10-31 | 5.7M | +8.9% | 4.90% | 1.2M | 4.6 |
| 2025-10-15 | 5.2M | -8.8% | 4.50% | 2.0M | 2.6 |
| 2025-09-30 | 5.7M | -2.4% | 4.93% | 1.6M | 3.7 |
| 2025-09-15 | 5.9M | -1.3% | 5.05% | 1.5M | 4.0 |
| 2025-08-29 | 6.0M | +8.3% | 5.12% | 1.2M | 4.9 |
| 2025-08-15 | 5.5M | +5.5% | 4.73% | 1.9M | 2.9 |